tirzepatide type 1 diabetes trial A Study of (LY3298176) Compared With Placebo in Adults With and Obesity or Overweight (SURPASS-T1D-1) Tirzepatide, a New Era of

Id worked so hard for the body I had, she said

In one trial, 638 patients randomized to 1 of 3 treatment arms following a 1-week lead-in period received: dapagliflozin 10 mg plus metformin HCl extended-release (up to 2,000 mg/day), dapagliflozin 10 mg plus placebo, or metformin HCl extended-release (up to 2,000 mg/day) plus placebo

With the exception of the normal control group exposed to normoxic conditions, the other groups were maintained in a hypobaric oxygen chamber that simulated an altitude of 6000 m for 28 days

Data will be made available after research completion and approval of the product and product use in the EU and the US